Skip to contentY
Yubo International Biotech Ltd
Y
YBGJYubo International Biotech Ltd Q1 2025 · 10-Q
Revenue$0.00$0.00−100.0% vs Q1 2024 Net Income-$435.63K-$435.63KN/M vs Q1 2024 EPS Diluted$0.00$0.00— vs Q1 2024 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Yubo International Biotech Ltd · CIK 895464 · Engraved from SEC EDGAR
Operating Cash Flow-$392,045N/M Free Cash Flowderived-$398,231N/M ended Mar 31, 2025 · filed May 14, 2025 · 44 d after period end